- Commonwealth Informatics provides a cloud-based product that leverages ‘advanced analytics’ to help clients improve drug safety
- Qinecsa is a provider of pharmacovigilance services and technologies to the global pharmaceutical industry
- The acquisition is Qinecsa’s second of 2022, following Reportum in April
Stanley Capital Partners’ portfolio company Qinecsa Solutions bought Commonwealth Informatics, a provider of a cloud-based product that leverages ‘advanced analytics’ to help clients improve drug safety.
Headquartered in Waltham, Massachusetts, Commonwealth uses end-to-end signal detection and risk management to improve drug safety. Its clients include large and medium-sized life science companies, government regulatory agencies, and public health organisations across the US, UK, Europe, and Asia.
The acquisition of Commonwealth provides a “significant step” for Qinecsa and its clients, according to Stanley Capital. The transaction combines pharmacovigilance services with a proven and scalable platform for the digital capture, processing, analysis, and reporting of safety data.
Commonwealth is London-based Qinecsa’s second acquisition of 2022, following the purchase of case intake and digital workflow platform Reportum in April.
“The joining together of Commonwealth and Qinecsa represents a great opportunity for growth in the pharmacovigilance space, and we are proud to be supporting the development of a leader in the market,” said Simon Cottle, SCP founding partner. “The acquisition also supports SCP’s strategy of keeping Qinecsa at the forefront of specialist service provision.”
London-based Stanley Capital is a European and US focused mid-market active equity investor.